OnKure Therapeutics, Inc. (OKUR) stock
OKURNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.82+0.24 (+9.30%)
Close on Nov 18, 2026Market cap $114.20MP/E –Yield –
OnKure Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2024 it was $0.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $0 | – |
See a number that looks wrong?